Transvascular Implantation of an Implantable Cardioverter-Defibrillator in a Patient Who has Undergone One-and-a-Half Ventricle Repair

Implantable cardioverter-defibrillator (ICD) therapy is acknowledged as a valid treatment method for the effective prevention of sudden cardiac death, which is a major cause of mortality in adult congenital heart disease patients. But ICD implantation by the conventional transvascular approach is no...

Full description

Saved in:
Bibliographic Details
Published inKorean circulation journal Vol. 45; no. 4; pp. 344 - 347
Main Authors Yang, Pil-Sung, Park, Je Wook, Lee, Yong-Joon, Kim, Dong-Jun, You, Seng Chan, Park, Dong Hyuk, Uhm, Jae-Sun, Kim, Nam Kyun
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society of Cardiology 01.07.2015
대한심장학회
Subjects
Online AccessGet full text
ISSN1738-5520
1738-5555
DOI10.4070/kcj.2015.45.4.344

Cover

Loading…
More Information
Summary:Implantable cardioverter-defibrillator (ICD) therapy is acknowledged as a valid treatment method for the effective prevention of sudden cardiac death, which is a major cause of mortality in adult congenital heart disease patients. But ICD implantation by the conventional transvascular approach is not always possible in patients who have undergone palliative surgery due to congenital and structural heart disease. Here, we report a case in which an ICD was transvascularly implanted in an arrhythmogenic right ventricular cardiomyopathy patient who had undergone a one-and-a-half ventricle repair.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000708.2015.45.4.012
ISSN:1738-5520
1738-5555
DOI:10.4070/kcj.2015.45.4.344